| Hormone BC TNT |
Hormone Receptor TNT for Breast cancer (endocrine therapy) |
Unfinished |
2025-07-03 |
mrgarci3 |
6 |
0 |
edit |
|
| pulmonary Drugs |
pulmonary Drugs for asthma and COPD |
Unfinished |
2023-04-17 |
mrgarci3 |
50 |
0 |
edit |
|
| quiz 2/ bugs-drugs |
quiz 2/ bugs-drugs |
Unfinished |
2023-09-12 |
mrgarci3 |
43 |
0 |
edit |
|
| Neuro/Psych 1 |
Neuro/Psych 1 |
Unfinished |
2024-01-29 |
mrgarci3 |
16 |
0 |
edit |
|
| Neuro/Psych 4 |
Neuro/Psych 4 |
Unfinished |
2024-01-07 |
mrgarci3 |
26 |
0 |
edit |
|
| HEENT 1 |
HEENT 1 |
Unfinished |
2024-01-05 |
mrgarci3 |
38 |
0 |
edit |
|
| HEENT 2 |
HEENT 2 |
Unfinished |
2024-01-06 |
mrgarci3 |
39 |
0 |
edit |
|
| Endo 1 |
Endo 1 |
Unfinished |
2024-01-07 |
mrgarci3 |
37 |
0 |
edit |
|
| Endo 2 |
Endo 2 |
Unfinished |
2024-01-07 |
mrgarci3 |
9 |
0 |
edit |
|
| ENDO 3 |
ENDO 3 |
Unfinished |
2024-01-08 |
mrgarci3 |
6 |
0 |
edit |
|
| Pain/Hem/ONC 1 |
Pain/Hem/ONC 1 |
Unfinished |
2024-01-09 |
mrgarci3 |
13 |
0 |
edit |
|
| Renal |
Renal |
Unfinished |
2024-01-09 |
mrgarci3 |
17 |
0 |
edit |
|
| ID 1 |
ID 1 |
Unfinished |
2024-01-09 |
mrgarci3 |
13 |
0 |
edit |
|
| ID 4 |
ID 4 |
Unfinished |
2024-01-11 |
mrgarci3 |
11 |
0 |
edit |
|
| CV 1 |
CV 1 |
Unfinished |
2024-01-11 |
mrgarci3 |
24 |
0 |
edit |
|
| ID 3 |
ID 3 |
Unfinished |
2024-02-08 |
mrgarci3 |
7 |
0 |
edit |
|
| Law Definitions |
Law Definitions |
Unfinished |
2024-01-16 |
mrgarci3 |
15 |
0 |
edit |
|
| CV 2 |
CV 2 |
Unfinished |
2024-01-29 |
mrgarci3 |
15 |
0 |
edit |
|
| CV 3 |
CV 3 |
Unfinished |
2024-01-29 |
mrgarci3 |
10 |
0 |
edit |
|
| CV 4 |
CV 4 |
Unfinished |
2024-01-28 |
mrgarci3 |
12 |
0 |
edit |
|
| Neuro 5 |
Neuro 5 |
Unfinished |
2024-01-30 |
mrgarci3 |
11 |
0 |
edit |
|
| Pulmonary |
Pulmonary |
Unfinished |
2024-02-08 |
mrgarci3 |
14 |
0 |
edit |
|
| ID2 |
ID 2 |
Unfinished |
2024-02-08 |
mrgarci3 |
10 |
0 |
edit |
|
| Neuro 3 |
Neuro 3 |
Unfinished |
2024-02-12 |
mrgarci3 |
9 |
0 |
edit |
|
| Law-chapter A |
LAW-Chapter A- major amendments |
Unfinished |
2024-02-15 |
mrgarci3 |
14 |
0 |
edit |
|
| Chapter A |
Chapter A |
Unfinished |
2024-02-15 |
mrgarci3 |
52 |
0 |
edit |
|
| chapter D LAW |
chapter D LAW |
Unfinished |
2024-02-18 |
mrgarci3 |
14 |
0 |
edit |
|
| Law Chpt.B questions |
Chapter B questions |
Unfinished |
2024-02-19 |
mrgarci3 |
72 |
0 |
edit |
|
| MSK |
MSK |
Unfinished |
2024-02-18 |
mrgarci3 |
19 |
0 |
edit |
|
| Neuro 2 |
Neuro 2 |
Unfinished |
2024-02-18 |
mrgarci3 |
11 |
0 |
edit |
|
| oncology drugs |
oncology drugs |
Unfinished |
2024-02-22 |
mrgarci3 |
70 |
0 |
edit |
|
| Stack #4106094 |
Pain/Hem/Onc 2 |
Unfinished |
2024-02-25 |
mrgarci3 |
6 |
0 |
edit |
|
| GI 1 drugs |
GI 1 drugs |
Unfinished |
2024-03-17 |
mrgarci3 |
13 |
0 |
edit |
|
| gI 2 drugs |
gI 2 drugs |
Unfinished |
2024-04-02 |
mrgarci3 |
8 |
0 |
edit |
|
| HIV meds |
HIV meds |
Unfinished |
2025-04-15 |
mrgarci3 |
51 |
0 |
edit |
|
| Oncology drugs |
side effects and treatment |
Unfinished |
2025-04-25 |
mrgarci3 |
4 |
0 |
edit |
|
| Oncology drugs exam3 |
Oncology drugs exam3 |
Unfinished |
2025-07-03 |
mrgarci3 |
28 |
0 |
edit |
|
| Diagnostic tests |
Diagnostic tests |
Unfinished |
2025-04-30 |
mrgarci3 |
31 |
0 |
edit |
|
| Natural products |
Natural products |
Unfinished |
2025-05-19 |
mrgarci3 |
73 |
0 |
edit |
|
| Teratogenic meds |
Teratogenic meds |
Unfinished |
2025-06-16 |
mrgarci3 |
8 |
0 |
edit |
|
| Dissociation factors |
Dissociation factors |
Unfinished |
2025-06-16 |
mrgarci3 |
8 |
0 |
edit |
|
| Diabetes |
Diabetes |
Unfinished |
2025-06-21 |
mrgarci3 |
84 |
0 |
edit |
|
| GERD |
GERD |
Unfinished |
2025-06-21 |
mrgarci3 |
35 |
0 |
edit |
|
| PUD |
PUD |
Unfinished |
2025-06-21 |
mrgarci3 |
18 |
0 |
edit |
|
| Thyroid Disorders |
Thyroid Disorders |
Unfinished |
2025-06-22 |
mrgarci3 |
67 |
0 |
edit |
|
| Sexual dysfunction |
Sexual dysfunction |
Unfinished |
2025-06-22 |
mrgarci3 |
23 |
0 |
edit |
|
| Hypertension |
Hypertension |
Unfinished |
2025-06-23 |
mrgarci3 |
99 |
0 |
edit |
|
| Arrthymias |
Arrthymias |
Unfinished |
2025-06-25 |
mrgarci3 |
32 |
0 |
edit |
|
| COMMON CV DI |
COMMON CV DI |
Unfinished |
2025-06-30 |
mrgarci3 |
6 |
0 |
edit |
|
| Inhibitor substrates |
increasse substrate drugs |
Unfinished |
2025-07-01 |
mrgarci3 |
5 |
0 |
edit |
|
| Inducers substrates |
Inducers decrease substrate drugs |
Unfinished |
2025-07-01 |
mrgarci3 |
5 |
0 |
edit |
|
| Drugs w/ADDed RISK |
DRUGS with additive risk and classes |
Unfinished |
2025-07-01 |
mrgarci3 |
8 |
0 |
edit |
|
| CYP450 enzymes |
CYP450 enzymes |
Unfinished |
2025-07-01 |
mrgarci3 |
17 |
0 |
edit |
|
| Rep. Monoclonal AB |
Represenative monoclonal antibodies |
Unfinished |
2025-07-03 |
mrgarci3 |
14 |
0 |
edit |
|
| TKI |
Tyrosine Kinase inhibitors |
Unfinished |
2025-07-03 |
mrgarci3 |
9 |
0 |
edit |
|
| PC androgen TNT |
Hormone therpies for Prostate cancer (androgen deprivation therapy) |
Unfinished |
2025-07-03 |
mrgarci3 |
13 |
0 |
edit |
|
| Cancer hyperca |
Hypercalcemia of malignancy |
Unfinished |
2025-07-03 |
mrgarci3 |
5 |
0 |
edit |
|
| Neutropenia/anemia |
Neutropenia/anemia chemo-related |
Unfinished |
2025-07-03 |
mrgarci3 |
17 |
0 |
edit |
|
| Chemo NV |
Chemo induced N/V |
Unfinished |
2025-07-03 |
mrgarci3 |
34 |
0 |
edit |
|
